DiaMedica Therapeutics Inc (DMAC)
DiaMedica Therapeutics Market Cap: 120.35M for May 16, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 16, 2024 | 120.35M |
May 15, 2024 | 114.27M |
May 14, 2024 | 114.65M |
May 13, 2024 | 121.10M |
May 10, 2024 | 118.45M |
May 09, 2024 | 123.38M |
May 08, 2024 | 131.73M |
May 07, 2024 | 138.95M |
May 06, 2024 | 132.87M |
May 03, 2024 | 113.89M |
May 02, 2024 | 99.85M |
May 01, 2024 | 98.33M |
April 30, 2024 | 96.05M |
April 29, 2024 | 98.33M |
April 26, 2024 | 97.57M |
April 25, 2024 | 96.05M |
April 24, 2024 | 93.01M |
April 23, 2024 | 91.87M |
April 22, 2024 | 95.29M |
April 19, 2024 | 90.73M |
April 18, 2024 | 94.53M |
April 17, 2024 | 98.71M |
April 16, 2024 | 89.97M |
April 15, 2024 | 90.73M |
April 12, 2024 | 92.25M |
Date | Value |
---|---|
April 11, 2024 | 96.43M |
April 10, 2024 | 100.60M |
April 09, 2024 | 102.88M |
April 08, 2024 | 105.54M |
April 05, 2024 | 113.13M |
April 04, 2024 | 111.99M |
April 03, 2024 | 106.30M |
April 02, 2024 | 103.64M |
April 01, 2024 | 103.64M |
March 28, 2024 | 105.14M |
March 27, 2024 | 100.59M |
March 26, 2024 | 103.25M |
March 25, 2024 | 101.73M |
March 22, 2024 | 104.38M |
March 21, 2024 | 102.11M |
March 20, 2024 | 105.14M |
March 19, 2024 | 107.04M |
March 18, 2024 | 108.18M |
March 15, 2024 | 115.01M |
March 14, 2024 | 110.84M |
March 13, 2024 | 110.08M |
March 12, 2024 | 109.70M |
March 11, 2024 | 110.46M |
March 08, 2024 | 116.15M |
March 07, 2024 | 116.53M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
NextCure Inc | 46.16M |
NovaBay Pharmaceuticals Inc | 4.540M |
Palatin Technologies Inc | 32.92M |
iBio Inc | 6.307M |
Theriva Biologics Inc | 6.462M |
Market Cap Related Metrics
Price to Book Value | 2.596 |
Price | 3.17 |
Earnings Yield | -17.67% |